Head and neck adnexal skin cancers.
3/5 보강
TL;DR
Adnexal carcinomas are classified into good, intermediate or poor prognosis categories based on the risk of local recurrence and distant metastasis, and this classification assists in determining the need for adjuvant treatments and follow-up strategies.
OpenAlex 토픽 ·
Cancer and Skin Lesions
Nonmelanoma Skin Cancer Studies
Salivary Gland Tumors Diagnosis and Treatment
Adnexal carcinomas are classified into good, intermediate or poor prognosis categories based on the risk of local recurrence and distant metastasis, and this classification assists in determining the
APA
Cecilia Molendi, Alessandra Sordi, et al. (2026). Head and neck adnexal skin cancers.. Current opinion in otolaryngology & head and neck surgery, 34(2), 67-78. https://doi.org/10.1097/MOO.0000000000001097
MLA
Cecilia Molendi, et al.. "Head and neck adnexal skin cancers.." Current opinion in otolaryngology & head and neck surgery, vol. 34, no. 2, 2026, pp. 67-78.
PMID
41259239 ↗
Abstract 한글 요약
[PURPOSE OF REVIEW] Adnexal carcinomas (AC) are rare skin lesions predominantly affecting elderly individuals. These tumors are often located in the head and neck region and are influenced by factors such as sun exposure, prior radiation therapy, and immunosuppression. Understanding the pathogenesis and management of AC is crucial for improving patient outcomes.
[RECENT FINDINGS] AC may arise de novo or from preexisting benign lesions. They may act as cutaneous markers for hereditary syndromes, highlighting the need for their early identification. Accurate diagnosis is critical, requiring adequate biopsy for proper characterization, as superficial excisions may lead to mistakes. Surgical treatment remains the primary approach, with wide (at least 1 cm) surgical margins also recommended for lesions with lower malignancy potential. Mohs surgery is particularly useful for tumors located in cosmetically sensitive areas, offering precise resection and clear margins.
[SUMMARY] AC are classified into good, intermediate or poor prognosis categories based on the risk of local recurrence and distant metastasis. This classification assists in determining the need for adjuvant treatments and follow-up strategies. The proper understanding of risk factors, pathogenesis, and treatment options is essential to improve outcomes and ensure optimal management of AC.
[RECENT FINDINGS] AC may arise de novo or from preexisting benign lesions. They may act as cutaneous markers for hereditary syndromes, highlighting the need for their early identification. Accurate diagnosis is critical, requiring adequate biopsy for proper characterization, as superficial excisions may lead to mistakes. Surgical treatment remains the primary approach, with wide (at least 1 cm) surgical margins also recommended for lesions with lower malignancy potential. Mohs surgery is particularly useful for tumors located in cosmetically sensitive areas, offering precise resection and clear margins.
[SUMMARY] AC are classified into good, intermediate or poor prognosis categories based on the risk of local recurrence and distant metastasis. This classification assists in determining the need for adjuvant treatments and follow-up strategies. The proper understanding of risk factors, pathogenesis, and treatment options is essential to improve outcomes and ensure optimal management of AC.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.